<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03898830</url>
  </required_header>
  <id_info>
    <org_study_id>D0000000135</org_study_id>
    <nct_id>NCT03898830</nct_id>
  </id_info>
  <brief_title>Eon™ FR Clinical Study Protocol 1064</brief_title>
  <official_title>A Prospective, Controlled, Standardized, Multi-center, Single-treatment, Single-arm Evaluation of the Eon™ FR 1064 nm Device to Reduce Abdominal Fat With a 12-week Observation Interval to Assess Safe Fat Reduction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dominion Aesthetic Technologies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dominion Aesthetic Technologies, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the treatment of subjects with the eon™ FR 1064 nm device in a single&#xD;
      session to thermally induce apoptosis in adipose tissue.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study evaluates the treatment of subjects between 18-60 with the eon™ FR 1064 nm device&#xD;
      in a single session to thermally induce apoptosis in adipose tissue in the abdomen.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 8, 2018</start_date>
  <completion_date type="Actual">March 22, 2019</completion_date>
  <primary_completion_date type="Actual">March 22, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Photographic Evaluations as a Measure of Effectiveness</measure>
    <time_frame>12 weeks</time_frame>
    <description>Photographs of the treatment area will be obtained at baseline and 12 weeks post treatment and be evaluated by blinded independent readers to correctly identify pre-treatment (baseline) photographs compared to 12 weeks post treatment photographs in order to determine effectiveness of device.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Circumferential Measurements to Evaluate Reduction in Adipose Layer Thickness</measure>
    <time_frame>12 weeks</time_frame>
    <description>Circumferential measurements of the treatment area will be completed and evaluated in comparison to the baseline results to determine the reduction in adipose layer thickness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ultrasound Measurement to Evaluate Reduction in Adipose Layer Thickness</measure>
    <time_frame>12 weeks</time_frame>
    <description>Ultrasound of the treatment area will be performed and evaluated in comparison to the baseline results to determine the reduction in adipose layer thickness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Questionnaire to determine Subject Satisfaction</measure>
    <time_frame>12 weeks</time_frame>
    <description>Subject Questionnaires will be completed by subjects at the end of study to determine the subject satisfaction with procedure.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Fat Disorder</condition>
  <arm_group>
    <arm_group_label>eon™ FR 1064 nm device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will be treated with the eon™ FR 1064 nm device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>eon™ FR 1064 nm device</intervention_name>
    <description>The subject treatment area - abdomen, was treated with the 1064 nm wavelength laser.</description>
    <arm_group_label>eon™ FR 1064 nm device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Body Mass Index (BMI) of 30 kg/m2 or less.&#xD;
&#xD;
          -  Healthy male or female between the ages of 21 and 60.&#xD;
&#xD;
          -  Had, at least 25 mm thickness adipose tissue on abdomen.&#xD;
&#xD;
          -  Able to read, understand and sign the Informed Consent Form (ICF).&#xD;
&#xD;
          -  Willing and able to adhere to the treatment and follow-up schedule and post-treatment&#xD;
             care instructions.&#xD;
&#xD;
          -  Willing to have limited sun exposure for the duration of the study, including the&#xD;
             follow-up period.&#xD;
&#xD;
          -  Willing to have photographs and ultrasound measurements taken of the treated area,&#xD;
             which could be used de-identified in evaluations and could be used de-identified in&#xD;
             presentations and/or publications.&#xD;
&#xD;
          -  Female subjects were either post-menopausal, surgically sterilized, or used a&#xD;
             medically acceptable form of birth control during the entire course of the study.&#xD;
&#xD;
          -  Female subjects with child bearing potential were willing to take a urine pregnancy&#xD;
             test and the result must be negative.&#xD;
&#xD;
          -  Agreed to maintain their current diet and exercise habits and not be specifically&#xD;
             trying to lose weight.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Aesthetic fat reduction procedure in the treatment area within the previous year.&#xD;
&#xD;
          -  Age less than 21 or greater than 60 years old.&#xD;
&#xD;
          -  Female subject pregnant or planning to become pregnant during the study duration,&#xD;
&#xD;
          -  Had an infection, dermatitis or a rash in the treatment area.&#xD;
&#xD;
          -  Had tattoos or jewelry in the treatment area.&#xD;
&#xD;
          -  Had a history of keloid scarring, hypertrophic scarring or of abnormal wound healing.&#xD;
&#xD;
          -  Had a history of immunosuppression/immune deficiency disorders or currently using&#xD;
             immunosuppressive medications.&#xD;
&#xD;
          -  Had a history of a known bleeding disorder.&#xD;
&#xD;
          -  Had a known photosensitivity to the study laser wavelength, history of ingesting.&#xD;
             medications known to induce photosensitivity, or history of seizure disorders due to&#xD;
             light.&#xD;
&#xD;
          -  Had known collagen, vascular disease or scleroderma.&#xD;
&#xD;
          -  Underwent a surgery or procedure in the treatment area within 6 months of treatment,&#xD;
             which is still healing.&#xD;
&#xD;
          -  Had underwent a fat reduction procedure in the treatment area within the past 12&#xD;
             months.&#xD;
&#xD;
          -  Had a significant concurrent illness, such as insulin-dependent diabetes, peripheral&#xD;
             vascular disease or peripheral neuropathy.&#xD;
&#xD;
          -  Underwent systemic chemotherapy for the treatment of cancer.&#xD;
&#xD;
          -  Used gold therapy for disorders such as rheumatologic disease or lupus.&#xD;
&#xD;
          -  Participated in a study of another device or drug within three months prior to&#xD;
             enrollment or during the study.&#xD;
&#xD;
          -  As per the investigator's discretion, the subject had any physical or mental condition&#xD;
             which might make it unsafe for the subject to participate in this study.&#xD;
&#xD;
          -  Concurrent use of steroids or secondary rheumatoid drugs.&#xD;
&#xD;
          -  Prior liposuction or a tummy tuck in the study area.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Laser &amp; Skin Surgery Center of Northern</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fiala Aesthetics</name>
      <address>
        <city>Altamonte Springs</city>
        <state>Florida</state>
        <zip>32701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Dermatology &amp; Laser Research</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 28, 2019</study_first_submitted>
  <study_first_submitted_qc>March 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>May 16, 2020</last_update_submitted>
  <last_update_submitted_qc>May 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adipose tissue, abdominal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipid Metabolism Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

